Proteomic Alterations of HDL in Youth with Type 1 Diabetes and Their Associations with Glycemic Control: a Case-control Study

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2019 Mar 30

PMID 30922315

Citations 28

Authors

Evgenia Gourgari

Junfeng Ma

Martin P Playford

Nehal N Mehta

Radoslav Goldman

Alan T Remaley

Scott M Gordon

Affiliations

Soon will be listed here.

Abstract

Background: Patients with type 1 diabetes (T1DM) typically have normal or even elevated plasma high density lipoprotein (HDL) cholesterol concentrations; however, HDL protein composition can be altered without a change in cholesterol content. Alteration of the HDL proteome can result in dysfunctional HDL particles with reduced ability to protect against cardiovascular disease (CVD). The objective of this study was to compare the HDL proteomes of youth with T1DM and healthy controls (HC) and to evaluate the influence of glycemic control on HDL protein composition.

Methods: This was a cross-sectional case-control study. Blood samples were obtained from patients with T1DM and HC. HDL was isolated from plasma by size-exclusion chromatography and further purified using a lipid binding resin. The HDL proteome was analyzed by mass spectrometry using label-free SWATH peptide quantification.

Results: Samples from 26 patients with T1DM and 13 HC were analyzed and 78 HDL-bound proteins were measured. Youth with T1DM had significantly increased amounts of complement factor H related protein 2 (FHR2; adjusted P < 0.05), compared to HC. When patients were analyzed based on glucose control, several trends emerged. Some proteins were altered in T1DM and not influenced by glycemic control (e.g. FHR2) while others were partially or completely corrected with optimal glucose control (e.g. alpha-1-beta glycoprotein, A1BG). In a subgroup of poorly controlled T1DM patients, inter alpha trypsin inhibitor 4 (ITIH4) was dramatically elevated (P < 0.0001) and this was partially reversed in patients with optimal glucose control. Some proteins including complement component C3 (CO3) and albumin (ALB) were significantly different only in T1DM patients with optimal glucose control, suggesting a possible effect of exogenous insulin.

Conclusions: Youth with T1DM have proteomic alterations of their HDL compared to HC, despite similar concentration of HDL cholesterol. The influence of these compositional changes on HDL function are not yet known. Future efforts should focus on investigating the role of these HDL associated proteins in regard to HDL function and their role in CVD risk in patients with T1DM. Trial registration NCT02275091.

Citing Articles

Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses.

Naqvi I, Bandyopadhyay A, Panda A, Hareramadas B Reprod Sci. 2025; 32(3):618-646.

PMID: 39875694 DOI: 10.1007/s43032-025-01789-8.

Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition.

Andersen C, Fernandez M Nutrients. 2025; 17(1.

PMID: 39796476 PMC: 11722654. DOI: 10.3390/nu17010042.

Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis.

Yi M, Toribio A, Salem Y, Alexander M, Ferrey A, Swentek L Int J Mol Sci. 2024; 25(11).

PMID: 38892018 PMC: 11172493. DOI: 10.3390/ijms25115831.

High-density lipoprotein in diabetes: Structural and functional relevance.

Lui D, Tan K J Diabetes Investig. 2024; 15(7):805-816.

PMID: 38416054 PMC: 11215696. DOI: 10.1111/jdi.14172.

The Complex Network of Cytokines and Chemokines in Pediatric Patients with Long-Standing Type 1 Diabetes.

Woloszyn-Durkiewicz A, Iwaszkiewicz-Grzes D, Swieton D, Kujawa M, Jankowska A, Durawa A Int J Mol Sci. 2024; 25(3).

PMID: 38338843 PMC: 10855710. DOI: 10.3390/ijms25031565.

References

Sleddering M, Markvoort A, Dharuri H, Jeyakar S, Snel M, Juhasz P . Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers. PLoS One. 2014; 9(11):e112835. PMC: 4240577. DOI: 10.1371/journal.pone.0112835. View

Tian M, Cui Y, Song G, Zong M, Zhou X, Chen Y . Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer. 2008; 8:241. PMC: 2528014. DOI: 10.1186/1471-2407-8-241. View

Mi H, Muruganujan A, Casagrande J, Thomas P . Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013; 8(8):1551-66. PMC: 6519453. DOI: 10.1038/nprot.2013.092. View

Chien S, Chen C, Leu H, Su C, Yin W, Tseng W . Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease. Int J Cardiol. 2017; 241:1-5. DOI: 10.1016/j.ijcard.2017.04.003. View

Holzer M, Wolf P, Curcic S, Birner-Gruenberger R, Weger W, Inzinger M . Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res. 2012; 53(8):1618-24. PMC: 3540842. DOI: 10.1194/jlr.M027367. View

Persegol L, Foissac M, Lagrost L, Athias A, Gambert P, Verges B . HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia. 2007; 50(11):2384-7. DOI: 10.1007/s00125-007-0808-8. View

Jozsi M, Zipfel P . Factor H family proteins and human diseases. Trends Immunol. 2008; 29(8):380-7. DOI: 10.1016/j.it.2008.04.008. View

Gourgari E, Dabelea D, Rother K . Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?. Curr Diab Rep. 2017; 17(12):134. PMC: 5670186. DOI: 10.1007/s11892-017-0968-y. View

Hovland A, Jonasson L, Garred P, Yndestad A, Aukrust P, Lappegard K . The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis. Atherosclerosis. 2015; 241(2):480-94. DOI: 10.1016/j.atherosclerosis.2015.05.038. View

10.

Birner-Gruenberger R, Schittmayer M, Holzer M, Marsche G . Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology. Prog Lipid Res. 2014; 56:36-46. DOI: 10.1016/j.plipres.2014.07.003. View

11.

Maahs D, Daniels S, de Ferranti S, Dichek H, Flynn J, Goldstein B . Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014; 130(17):1532-58. DOI: 10.1161/CIR.0000000000000094. View

12.

Haapasalo K, van Kessel K, Nissila E, Metso J, Johansson T, Miettinen S . Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles. J Biol Chem. 2015; 290(48):28977-87. PMC: 4661410. DOI: 10.1074/jbc.M115.669226. View

13.

Gordon S, McKenzie B, Kemeh G, Sampson M, Perl S, Young N . Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties. Mol Cell Proteomics. 2015; 14(12):3247-57. PMC: 4762624. DOI: 10.1074/mcp.M115.054031. View

14.

Diz A, Carvajal-Rodriguez A, Skibinski D . Multiple hypothesis testing in proteomics: a strategy for experimental work. Mol Cell Proteomics. 2011; 10(3):M110.004374. PMC: 3047155. DOI: 10.1074/mcp.M110.004374. View

15.

Maahs D, Maniatis A, Nadeau K, Wadwa R, McFann K, Klingensmith G . Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr. 2005; 147(4):544-6. DOI: 10.1016/j.jpeds.2005.04.068. View

16.

Vaisar T, Pennathur S, Green P, Gharib S, Hoofnagle A, Cheung M . Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest. 2007; 117(3):746-56. PMC: 1804352. DOI: 10.1172/JCI26206. View

17.

Mehta N, Li R, Krishnamoorthy P, Yu Y, Farver W, Rodrigues A . Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis. 2012; 224(1):218-21. PMC: 3693845. DOI: 10.1016/j.atherosclerosis.2012.06.068. View

18.

Groop P, Thomas M, Rosengard-Barlund M, Mills V, Ronnback M, Thomas S . HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care. 2007; 30(10):2706-7. DOI: 10.2337/dc07-0030. View

19.

Alwaili K, Bailey D, Awan Z, Bailey S, Ruel I, Hafiane A . The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta. 2011; 1821(3):405-15. DOI: 10.1016/j.bbalip.2011.07.013. View

20.

Soggiu A, Piras C, Bonizzi L, Hussein H, Pisanu S, Roncada P . A discovery-phase urine proteomics investigation in type 1 diabetes. Acta Diabetol. 2012; 49(6):453-64. DOI: 10.1007/s00592-012-0407-0. View